Clinical Trial Update: A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating CM326 for moderate to severe asthma is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Severe Asthma

Drugs mentioned

• CM326

Snippet

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Conditions: Moderate to Severe Asthma | Phase 3 | Status: NOT_YET_RECRUITING